Penetrating keratoplasty in Mooren's ulcer

American Journal of Ophthalmology
S I Brown, B J Mondino

Abstract

Two patients had bilateral, simultaneous Mooren's ulcers that progressed to almost total loss of the corneal stroma in all eyes. The conjunctival epithelium eventually healed over these thinned corneas and the eyes were free of pain and inflammation. Three of the four eyes had combined 7.5-mm penetrating corneal transplants and cataract extractions performed at least four months after disease activity had subsided. All transplants have remained transparent from one to three years postoperatively and there has been no evidence of recurrence of Mooren's ulcers.

References

May 1, 1968·American Journal of Ophthalmology·B Kietzman
Sep 1, 1959·Archives of Ophthalmology·P C GRANA

❮ Previous
Next ❯

Citations

Jan 15, 1987·American Journal of Ophthalmology·B J MondinoR Y Foos
Jan 1, 1989·Eye·C M KirknessA D Steele
Jan 31, 1985·Documenta Ophthalmologica. Advances in Ophthalmology·P J KruitJ S Stilma
Jul 1, 1983·The British Journal of Ophthalmology·J S Stilma
Jul 1, 1986·Digestive Diseases and Sciences·S C MooreA R Zinsmeister
Nov 11, 2015·The British Journal of Ophthalmology·Ikeda LalJayesh Vazirani
Dec 24, 2010·Clinical & Experimental Ophthalmology·Nguyen D Ngan, Hoang T M Chau
Oct 17, 2020·Vestnik oftalmologii·E A KasparovaE M Kruglova
Jul 1, 1989·Survey of Ophthalmology·S L PortnoyH E Kaufman
Jul 1, 1986·Survey of Ophthalmology·J B RobinH E Kaufman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

American Journal of Ophthalmology
B J MondinoJ P Mondzelewski
Transactions of the Ophthalmological Societies of the United Kingdom
S I Brown
American Journal of Ophthalmology
S I Brown, B J Mondino
© 2021 Meta ULC. All rights reserved